First Affiliated Hospital of Zhejiang University School of Medicine

Hangzhou, Zhejiang 310003

1 studies enrolling now · 2 studies all time

What they study most

Advanced Lymphoma, Advanced Solid Tumor, HER2-Positive Advanced Solid Tumor, HER2-Positive Salivary Gland Carcinomas, HER2-positive Biliary Tract Cancer, HER2-positive Breast Cancer

Studies at this site

• A Study of CS5001 in Patients With Advanced Solid Tumors and Lymphomas — Recruiting now
• Safety of GQ1001 in Adult Patients With HER2-Positive Advanced Solid Tumors — Status unconfirmed